Letifend

RSS

Authorised

This medicine is authorised for use in the European Union

canine leishmaniasis vaccine (recombinant protein)
MedicineVeterinaryAuthorised

Romanian is available via eTranslation, the European Commission's machine translation service.

Translate to Romanian | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

български (BG) (93.36 KB - PDF)

Vizualizare

español (ES) (81.97 KB - PDF)

Vizualizare

čeština (CS) (93.99 KB - PDF)

Vizualizare

dansk (DA) (83.34 KB - PDF)

Vizualizare

Deutsch (DE) (82.76 KB - PDF)

Vizualizare

eesti (ET) (82.18 KB - PDF)

Vizualizare

ελληνικά (EL) (93.76 KB - PDF)

Vizualizare

français (FR) (82.44 KB - PDF)

Vizualizare

Gaeilge (GA) (83.57 KB - PDF)

Vizualizare

hrvatski (HR) (92.27 KB - PDF)

Vizualizare

italiano (IT) (82.29 KB - PDF)

Vizualizare

latviešu (LV) (94.29 KB - PDF)

Vizualizare

lietuvių (LT) (94.03 KB - PDF)

Vizualizare

magyar (HU) (94.15 KB - PDF)

Vizualizare

Malti (MT) (95.95 KB - PDF)

Vizualizare

Nederlands (NL) (82.05 KB - PDF)

Vizualizare

polski (PL) (95.62 KB - PDF)

Vizualizare

português (PT) (83.01 KB - PDF)

Vizualizare

română (RO) (94.17 KB - PDF)

Vizualizare

slovenčina (SK) (94.08 KB - PDF)

Vizualizare

slovenščina (SL) (82.27 KB - PDF)

Vizualizare

suomi (FI) (81.54 KB - PDF)

Vizualizare

svenska (SV) (82.05 KB - PDF)

Vizualizare

Íslenska (IS) (83.29 KB - PDF)

Vizualizare

norsk (NO) (82 KB - PDF)

Vizualizare

Product information

български (BG) (91.78 KB - PDF)

Vizualizare

español (ES) (81.51 KB - PDF)

Vizualizare

čeština (CS) (92.48 KB - PDF)

Vizualizare

dansk (DA) (82.05 KB - PDF)

Vizualizare

Deutsch (DE) (81.72 KB - PDF)

Vizualizare

eesti (ET) (81.22 KB - PDF)

Vizualizare

ελληνικά (EL) (91.79 KB - PDF)

Vizualizare

français (FR) (81.63 KB - PDF)

Vizualizare

Gaeilge (GA) (81.36 KB - PDF)

Vizualizare

hrvatski (HR) (91.56 KB - PDF)

Vizualizare

italiano (IT) (81.76 KB - PDF)

Vizualizare

latviešu (LV) (92.14 KB - PDF)

Vizualizare

lietuvių (LT) (92.19 KB - PDF)

Vizualizare

magyar (HU) (92.76 KB - PDF)

Vizualizare

Malti (MT) (93.86 KB - PDF)

Vizualizare

Nederlands (NL) (81.15 KB - PDF)

Vizualizare

polski (PL) (93.22 KB - PDF)

Vizualizare

português (PT) (82.53 KB - PDF)

Vizualizare

română (RO) (91.73 KB - PDF)

Vizualizare

slovenčina (SK) (81.75 KB - PDF)

Vizualizare

slovenščina (SL) (81.76 KB - PDF)

Vizualizare

suomi (FI) (81.11 KB - PDF)

Vizualizare

svenska (SV) (81.47 KB - PDF)

Vizualizare

Íslenska (IS) (81.52 KB - PDF)

Vizualizare

norsk (NO) (81.52 KB - PDF)

Vizualizare

български (BG) (93.36 KB - PDF)

Vizualizare

español (ES) (81.97 KB - PDF)

Vizualizare

čeština (CS) (93.99 KB - PDF)

Vizualizare

dansk (DA) (83.34 KB - PDF)

Vizualizare

Deutsch (DE) (82.76 KB - PDF)

Vizualizare

eesti (ET) (82.18 KB - PDF)

Vizualizare

ελληνικά (EL) (93.76 KB - PDF)

Vizualizare

français (FR) (82.44 KB - PDF)

Vizualizare

Gaeilge (GA) (83.57 KB - PDF)

Vizualizare

hrvatski (HR) (92.27 KB - PDF)

Vizualizare

italiano (IT) (82.29 KB - PDF)

Vizualizare

latviešu (LV) (94.29 KB - PDF)

Vizualizare

lietuvių (LT) (94.03 KB - PDF)

Vizualizare

magyar (HU) (94.15 KB - PDF)

Vizualizare

Malti (MT) (95.95 KB - PDF)

Vizualizare

Nederlands (NL) (82.05 KB - PDF)

Vizualizare

polski (PL) (95.62 KB - PDF)

Vizualizare

português (PT) (83.01 KB - PDF)

Vizualizare

română (RO) (94.17 KB - PDF)

Vizualizare

slovenčina (SK) (94.08 KB - PDF)

Vizualizare

slovenščina (SL) (82.27 KB - PDF)

Vizualizare

suomi (FI) (81.54 KB - PDF)

Vizualizare

svenska (SV) (82.05 KB - PDF)

Vizualizare

Íslenska (IS) (83.29 KB - PDF)

Vizualizare

norsk (NO) (82 KB - PDF)

Vizualizare

Product details

Name of medicine
Letifend
Active substance
recombinant protein Q from Leishmania infantum MON-1
International non-proprietary name (INN) or common name
canine leishmaniasis vaccine (recombinant protein)

Pharmacotherapeutic group

Inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia)

Authorisation details

EMA product number
EMEA/V/C/003865

Assessment history

This page was last updated on

Share this page